Sign Up
av/eterna-therapeutics--big.svg

COM:ETERNATX

Eterna

  • Stock

USD

Last Close

0.53

22/11 21:00

Market Cap

9.90M

Beta: -

Volume Today

113.60K

Avg: -

OverviewAnalysisMetricsFinancialsFilingsAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-475.50K
-
-475.50K
0%
average payables
1.51M
-
1.69M
11.39%
1.34M
20.39%
average receivables
342K
-
817.50K
139.04%
688K
15.84%
book value per share
70.83
-
3.69
94.79%
3.00
18.62%
3.97
32.15%
0.42
89.41%
capex per share
-15.22
-
-0.02
99.88%
-0.07
278.53%
-0.10
36.87%
-0.00
96.33%
capex to depreciation
-0.35
-
-0.40
15.24%
-0.34
15.69%
-0.60
78.11%
-0.02
97.17%
capex to operating cash flow
-0.40
-
0.00
101.21%
0.01
36.19%
0.01
115.95%
0.00
93.42%
capex to revenue
-0.06
-
-0.28
-
cash per share
45.34
-
0.79
98.27%
7.84
898.91%
3.75
52.17%
1.43
62.00%
days of inventory on hand
50.73
-
days payables outstanding
38.86
-
286.57
-
days sales outstanding
22.02
-
2.28K
-
debt to assets
0.40
-
0.41
2.15%
0.80
96.65%
0.19
76.77%
0.18
1.50%
debt to equity
1.19
-
0.69
42.64%
3.99
482.06%
0.34
91.43%
4.03
1,077.79%
dividend yield
0.00
-
0.00
-
0.00
3,576.34%
0.00
2.71%
earnings yield
-0.32
-
-0.04
87.89%
-0.68
1,627.63%
-2.50
269.40%
-2.27
9.46%
enterprise value
9.15M
-
187.25M
1,947.36%
166.32M
11.18%
2.52M
98.49%
43.83M
1,642.03%
enterprise value over ebitda
4.68
-
-26.19
660.09%
-1.37
94.78%
-0.08
94.25%
-2.24
2,754.10%
ev to operating cash flow
3.33
-
-23.11
793.49%
-7.08
69.36%
-0.12
98.31%
-2.15
1,690.51%
ev to sales
0.46
-
644.61
-
free cash flow per share
22.96
-
-3.92
117.08%
-10.92
178.42%
-6.97
36.14%
-3.84
44.87%
free cash flow yield
0.26
-
-0.04
116.78%
-0.13
199.12%
-2.17
1,553.98%
-2.14
1.38%
graham net net
-76.31
-
-1.74
97.72%
-3.89
123.40%
0.50
112.73%
-7.34
1,581.37%
graham number
213.05
-
17.08
91.98%
61.78
261.76%
26.82
56.59%
6.21
76.85%
income quality
-1.34
-
1.11
182.89%
0.19
82.72%
0.85
344.39%
0.94
10.36%
intangibles to total assets
0.05
-
0.62
1,266.28%
0.27
55.89%
0.09
66.59%
0.04
54.65%
interest coverage
-4.87
-
-168.56
3,362.95%
-1.53K
810.36%
-1.11K
27.84%
-33.67
96.96%
interest debt per share
88.06
-
1.42
98.39%
1.29
8.83%
1.37
5.76%
1.81
32.28%
inventory turnover
7.20
-
invested capital
1.19
-
0.38
68.32%
0.42
10.68%
0.34
18.39%
4.03
1,077.79%
market cap
6.33M
-
185.98M
2,840.45%
180.59M
2.90%
9.82M
94.56%
9.57M
2.64%
net current asset value
-4.12M
-
-3.52M
14.58%
-7.16M
103.73%
3.51M
149.00%
-37.30M
1,162.98%
net debt to ebitda
1.44
-
-0.18
112.30%
0.12
166.04%
0.23
94.79%
-1.75
868.25%
net income per share
-28.48
-
-3.51
87.67%
-56.48
1,508.08%
-8.06
85.74%
-4.08
49.39%
operating cash flow per share
38.18
-
-3.90
110.22%
-10.85
177.94%
-6.88
36.62%
-3.84
44.14%
payables turnover
9.39
-
1.27
-
receivables turnover
16.57
-
0.16
-
research and ddevelopement to revenue
0.00
-
87.06
-
return on tangible assets
-0.14
-
-1.50
965.91%
-5.20
247.41%
-1.21
76.64%
-0.46
62.12%
revenue per share
275.56
-
0.01
-
roe
-0.40
-
-0.95
136.76%
-18.81
1,875.99%
-2.03
89.21%
-9.70
377.97%
roic
-0.09
-
-0.87
892.74%
34.45
4,079.10%
-1.91
105.54%
-0.47
75.44%
sales general and administrative to revenue
214.51
-
shareholders equity per share
70.83
-
3.69
94.79%
3.00
18.62%
3.97
32.15%
0.42
89.41%
stock based compensation to revenue
18.26
-
tangible asset value
4.39M
-
-375K
108.53%
-2.40M
540.53%
10.06M
518.94%
189K
98.12%
tangible book value per share
61.15
-
-0.18
100.30%
-1.11
514.03%
3.30
397.32%
0.04
98.92%
working capital
-25K
-
-1.39M
5,472%
15.09M
1,183.20%
6.03M
60.06%
3.03M
49.79%

All numbers in USD (except ratios and percentages)